{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:45:14Z","timestamp":1791330314558,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.cld.2009.11.007","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T10:10:26Z","timestamp":1264500626000},"page":"169-176","source":"Crossref","is-referenced-by-count":60,"title":["Management of Acute Hepatitis C"],"prefix":"10.1016","volume":"14","author":[{"given":"Anurag","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2009.11.007_bib1","first-page":"421","article-title":"Hepatitis C \u2013 Global prevalence (update)","volume":"49","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.cld.2009.11.007_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkn346","article-title":"Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha","volume":"62","author":"Wiegand","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cld.2009.11.007_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM199107113250205","article-title":"A long-term study of hepatitis C virus replication in non-A, non-B hepatitis","volume":"325","author":"Farci","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.11.007_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hep.1840140107","article-title":"IgM antibody to hepatitis C virus in acute and chronic hepatitis C","volume":"14","author":"Quiroga","year":"1991","journal-title":"Hepatology"},{"issue":"RR-11","key":"10.1016\/j.cld.2009.11.007_bib5","first-page":"1","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cld.2009.11.007_bib6","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1002\/hep.1840360725","article-title":"Therapy of acute hepatitis C","volume":"36","author":"Alberti","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.11.007_bib7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0168-8278(03)00461-6","article-title":"When and how to treat acute hepatitis C?","volume":"39","author":"Licata","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2009.11.007_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/jhep.2003.50019","article-title":"Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load","volume":"37","author":"Hofer","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.11.007_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.11.007_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.gastro.2006.01.034","article-title":"Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response","volume":"130","author":"Kamal","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.11.007_bib11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.11.007_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santantonio","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.11.007_bib13","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1016\/S0168-8278(09)61049-7","article-title":"Early versus delayed treatment of acute Hepatitis C: the German HEP-NET acute HCV-III study \u2013 A randomized controlled trial","volume":"50","author":"Deterding","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.11.007_bib14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.20196","article-title":"Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial","volume":"39","author":"Nomura","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.11.007_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.21043","article-title":"Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study","volume":"43","author":"Wiegand","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.11.007_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhep.2004.11.018","article-title":"Swiss Association for the Study of the Liver (SASL 18). Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C","volume":"42","author":"Broers","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.11.007_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1086\/520660","article-title":"Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users","volume":"45","author":"De Rosa","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2009.11.007_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2893.2006.00802.x","article-title":"A short course of pegylated interferon-alpha in acute HCV hepatitis","volume":"14","author":"Calleri","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cld.2009.11.007_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dki458","article-title":"Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C","volume":"57","author":"De Rosa","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cld.2009.11.007_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.21197","article-title":"Duration of peginterferon therapy in acute hepatitis C: a randomized trial","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.11.007_bib21","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cgh.2006.06.026","article-title":"Outcomes and treatment of acute hepatitis C virus infection in a United States population","volume":"4","author":"Corey","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2009.11.007_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.qai.0000174930.64145.a9","article-title":"Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin","volume":"40","author":"Gilleece","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cld.2009.11.007_bib23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/01.aids.0000226956.02719.fd","article-title":"Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients","volume":"20","author":"Dominguez","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2009.11.007_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/135965350601100817","article-title":"Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals","volume":"11","author":"Vogel","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cld.2009.11.007_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/QAD.0b013e3281084e4d","article-title":"Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel","volume":"21","author":"Soriano","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2009.11.007_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.meg.0000252626.73172.f3","article-title":"Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance","volume":"19","author":"Rocha","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2009.11.007_bib27","first-page":"293","article-title":"Treatment of acute hepatitis C virus infection with alpha interferon in patients on hemodialysis","volume":"16","author":"Al-Harbi","year":"2005","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"10.1016\/j.cld.2009.11.007_bib28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/08860220701460160","article-title":"Acute hepatitis C in patients receiving hemodialysis","volume":"29","author":"Griveas","year":"2007","journal-title":"Ren Fail"},{"key":"10.1016\/j.cld.2009.11.007_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2893.2001.00268.x","article-title":"Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment","volume":"8","author":"G\u00fcrsoy","year":"2001","journal-title":"J Viral Hepat"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326109000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326109000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T19:24:26Z","timestamp":1685388266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326109000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1089326109000889"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2009.11.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}